New York, NY · NAICS 541714
Advancing novel therapies for autoimmune disease.
We are a clinical-stage biotechnology company researching and developing novel antibody therapies, with a focus on improving outcomes for people living with autoimmune and inflammatory diseases.
What we do
Therapeutic research
Discovery and optimisation of novel antibody candidates.
Preclinical development
Rigorous preclinical study to establish safety and mechanism.
Clinical programs
Carefully designed trials that test our candidates in patients.
Scientific partnerships
Collaborating with researchers and institutions to move science forward.
How we work
We are a clinical-stage biotechnology company developing novel therapies for autoimmune disease.
Service area
We serve New York and the surrounding area, including Manhattan, Brooklyn, Queens, Newark, Jersey City.
Get in touch
Tell us what you need and we will tell you, honestly, how we can help.